Article Information
History
- March 22, 2022.
Article Versions
- Version 1 (February 1, 2022 - 16:36).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Lena Landaverdea,b,c,
- Jacquelyn Turcinovicd,e,f,
- Lynn Doucette-Stammb,
- Kevin Gonzalesg,h,
- Judy Plattg,
- John H. Connord,e,f,i and
- Catherine Klappericha,b,c,*
- aDepartment of Biomedical Engineering, Boston University, Boston, MA, USA
- bClinical Testing Laboratory, Boston University, Boston, MA, USA
- cPrecision Diagnostics Center, BU, Boston, MA, USA
- dDepartment of Microbiology, Boston University School of Medicine, Boston, MA, USA
- eNational Emerging Infectious Diseases Laboratories, Boston University, Boston, MA, USA
- fProgram in Bioinformatics, Boston University, Boston, MA, USA
- gStudent Health Services, Healthway, Boston University, Boston, MA, USA
- hOffice of Research, Boston University, Boston, MA, USA
- iCenter for Emerging Infectious Disease Research and Policy, Boston University, Boston, MA, USA
- ↵* Corresponding author; email: catherin{at}bu.edu
Posted March 22, 2022.
Comparison of BinaxNOW™ and SARS-CoV-2 qRT-PCR detection of the Omicron Variant from Matched Anterior Nares Swabs
